Prof. Dr. Dr. Thomas Bieber
Department of Dermatology & Allergology
direktion.dermatologie@ukbonn.de View member: Prof. Dr. Dr. Thomas Bieber
Experimental dermatology
Dermatomyositis (DM) is an idiopathic inflammatory myopathy belonging to the spectrum of autoimmune connective tissue diseases. DM patients present with antinuclear antibodies against Mi-2, also known as Chromodomain-helicase-DNA-binding protein 4 (CHD4). CHD4 is upregulated in DM skin biopsies and could potentially affect DM pathophysiology as it binds endogenous DNA with a high affinity (KD = 0.2 nM ± 0.076 nM) and forms CHD4-DNA complexes. The complexes are localized in the cytoplasm of UV-radiated and transfected HaCaTs and amplify the expression of interferon (IFN) regulated genes and the amount of functional CXCL10 protein stronger than DNA alone. The enhancement of the type I IFN pathway activation in HaCaTs through CHD4-DNA signalling suggests a possible mechanism for the sustainment of the pro-inflammatory vicious cycle in DM skin lesions.
© 2023 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd.
PMID: 36995066
Department of Dermatology & Allergology
direktion.dermatologie@ukbonn.de View member: Prof. Dr. Dr. Thomas Bieber